Legacy Financial Advisors, Inc. Bristol Myers Squibb CO Transaction History

Legacy Financial Advisors, Inc.

$515 Million
Q3 2024

A detailed history of Legacy Financial Advisors, Inc. transactions in Bristol Myers Squibb CO stock. As of the latest transaction made, Legacy Financial Advisors, Inc. holds 10,057 shares of BMY stock, worth $592,055. This represents 0.1% of its overall portfolio holdings.

Number of Shares

10,057

Previous 9,518 5.66%

Holding current value

$592,055

Previous $395,000 31.65%

% of portfolio

0.1%

Previous 0.08%

26 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 13, 2024	BUY	$39.66 - $51.75 $21,376 - $27,893	539 Added 5.66%	10,057 $520,000
Q2 2024 Aug 13, 2024	BUY	$40.25 - $52.99 $168,607 - $221,975	4,189 Added 78.61%	9,518 $395,000
Q1 2024 May 14, 2024	BUY	$47.98 - $54.4 $2,111 - $2,393	44 Added 0.83%	5,329 $288,000
Q4 2023 Feb 06, 2024	SELL	$48.48 - $57.85 $79,507 - $94,874	-1,640 Reduced 23.68%	5,285 $271,000
Q3 2023 Nov 13, 2023	SELL	$57.89 - $64.73 $18,814 - $21,037	-325 Reduced 4.48%	6,925 $401,000
Q2 2023 Aug 08, 2023	SELL	$63.71 - $70.74 $30,325 - $33,672	-476 Reduced 6.16%	7,250 $463,000
Q1 2023 May 03, 2023	BUY	$65.71 - $74.53 $18,595 - $21,091	283 Added 3.8%	7,726 $535,000
Q4 2022 Feb 06, 2023	BUY	$68.48 - $81.09 $116,416 - $137,853	1,700 Added 29.6%	7,443 $535,000
Q3 2022 Nov 09, 2022	SELL	$0.13 - $76.84 $46 - $27,355	-356 Reduced 5.84%	5,743 $408,000
Q2 2022 Aug 08, 2022	BUY	$72.62 - $79.98 $91,791 - $101,094	1,264 Added 26.14%	6,099 $470,000
Q1 2022 May 04, 2022	BUY	$61.48 - $73.72 $22,870 - $27,423	372 Added 8.34%	4,835 $353,000
Q4 2021 Feb 04, 2022	BUY	$53.63 - $62.52 $11,369 - $13,254	212 Added 4.99%	4,463 $278,000
Q3 2021 Oct 26, 2021	BUY	$59.17 - $69.31 $25,265 - $29,595	427 Added 11.17%	4,251 $252,000
Q2 2021 Jul 21, 2021	SELL	$61.91 - $67.42 $52,128 - $56,767	-842 Reduced 18.05%	3,824 $256,000
Q1 2021 Apr 28, 2021	BUY	$59.34 - $66.74 $59,043 - $66,406	995 Added 27.1%	4,666 $295,000
Q4 2020 Feb 02, 2021	SELL	$57.74 - $65.43 $15,474 - $17,535	-268 Reduced 6.8%	3,671 $228,000
Q3 2020 Nov 09, 2020	BUY	$57.43 - $63.64 $226,216 - $250,677	3,939 New	3,939 $237,000
Q1 2020 May 12, 2020	SELL	$46.4 - $67.43 $194,555 - $282,733	-4,193 Closed	0 $0
Q4 2019 Jan 27, 2020	BUY	$49.21 - $64.19 $206,337 - $269,148	4,193 New	4,193 $269,000
Q2 2019 Aug 07, 2019	SELL	$44.62 - $49.34 $175,936 - $194,547	-3,943 Closed	0 $0
Q1 2019 May 14, 2019	SELL	$45.12 - $53.8 $46,969 - $56,005	-1,041 Reduced 20.89%	3,943 $188,000
Q4 2018 Jan 16, 2019	SELL	$48.76 - $63.23 $4,973 - $6,449	-102 Reduced 2.01%	4,984 $259,000
Q3 2018 Oct 30, 2018	SELL	$55.19 - $62.25 $67,055 - $75,633	-1,215 Reduced 19.28%	5,086 $315,000
Q2 2018 Jul 17, 2018	BUY	$50.53 - $62.98 $210,507 - $262,374	4,166 Added 195.13%	6,301 $358,000
Q1 2018 Apr 12, 2018	SELL	$59.92 - $68.98 $3,295 - $3,793	-55 Reduced 2.51%	2,135 $130,000
Q4 2017 Feb 09, 2018	BUY	$59.94 - $65.35 $131,268 - $143,116	2,190	2,190 $134,000

Others Institutions Holding BMY

# of Institutions

2,533

Shares Held

1.47B

Call Options Held

31.6M

Put Options Held

35M

View Full List

About BRISTOL MYERS SQUIBB CO

Ticker BMY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,126,160,000
Market Cap $125B
Description
Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...

More about BMY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Legacy Financial Advisors, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Legacy Financial Advisors, Inc. with notifications on news.

Account

Legacy Financial Advisors, Inc. Bristol Myers Squibb CO Transaction History